Motley Fool Wealth Management LLC Sells 14,144 Shares of HealthEquity, Inc. $HQY

Motley Fool Wealth Management LLC trimmed its stake in HealthEquity, Inc. (NASDAQ:HQY) by 14.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 87,171 shares of the company’s stock after selling 14,144 shares during the period. Motley Fool Wealth Management LLC’s holdings in HealthEquity were worth $7,986,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of HQY. Sivia Capital Partners LLC acquired a new stake in HealthEquity in the second quarter valued at $306,000. Arrowstreet Capital Limited Partnership acquired a new stake in HealthEquity in the second quarter valued at $4,747,000. Marshall Wace LLP acquired a new stake in HealthEquity in the second quarter valued at $5,483,000. Amundi increased its holdings in HealthEquity by 9.3% in the second quarter. Amundi now owns 30,203 shares of the company’s stock valued at $3,059,000 after purchasing an additional 2,574 shares during the period. Finally, Jump Financial LLC acquired a new stake in HealthEquity in the second quarter valued at $449,000. 99.55% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on HQY. Citigroup restated a “market outperform” rating on shares of HealthEquity in a report on Monday, June 1st. Jefferies Financial Group set a $108.00 price objective on HealthEquity in a report on Thursday, February 19th. Barrington Research restated an “outperform” rating and issued a $110.00 price objective on shares of HealthEquity in a report on Friday, May 22nd. BMO Capital Markets upgraded HealthEquity from a “market perform” rating to an “outperform” rating and increased their price objective for the company from $85.00 to $105.00 in a report on Thursday, April 9th. Finally, Citizens Jmp increased their price objective on HealthEquity from $110.00 to $111.00 and gave the company a “market outperform” rating in a report on Monday, June 1st. One equities research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $110.57.

HealthEquity Stock Performance

Shares of HealthEquity stock opened at $89.23 on Wednesday. The company has a current ratio of 3.44, a quick ratio of 3.44 and a debt-to-equity ratio of 0.46. The business has a 50-day moving average price of $84.27 and a two-hundred day moving average price of $86.03. HealthEquity, Inc. has a 1-year low of $72.76 and a 1-year high of $111.44. The company has a market cap of $7.46 billion, a P/E ratio of 33.42, a PEG ratio of 1.48 and a beta of 0.21.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings results on Thursday, May 28th. The company reported $1.24 earnings per share for the quarter, topping analysts’ consensus estimates of $1.11 by $0.13. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.The firm had revenue of $354.64 million during the quarter, compared to the consensus estimate of $352.02 million. The firm’s revenue was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. As a group, analysts anticipate that HealthEquity, Inc. will post 3.92 EPS for the current year.

Insiders Place Their Bets

In other HealthEquity news, Director Gayle Furgurson Wellborn sold 2,439 shares of the stock in a transaction dated Thursday, May 28th. The stock was sold at an average price of $90.00, for a total transaction of $219,510.00. Following the completion of the sale, the director directly owned 19,733 shares in the company, valued at approximately $1,775,970. This trade represents a 11.00% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Delano Ladd sold 7,500 shares of the stock in a transaction dated Thursday, May 28th. The stock was sold at an average price of $90.00, for a total transaction of $675,000.00. Following the transaction, the executive vice president directly owned 91,141 shares in the company, valued at $8,202,690. This trade represents a 7.60% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 13,081 shares of company stock worth $1,193,000. Company insiders own 1.60% of the company’s stock.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.